NicaPlant®
Undisclosed CNS condition(s) (High unmet medical need, life-threatening)
Pre-clinicalActive
Key Facts
Indication
Undisclosed CNS condition(s) (High unmet medical need, life-threatening)
Phase
Pre-clinical
Status
Active
Company
About BIT Pharma
BIT Pharma is a private, preclinical-stage biotech developing innovative drug delivery implants for the brain. Its core technology is a cGMP-compliant, synthetic, and biodegradable polymer system manufactured via hot melt extrusion, designed for localized and sustained drug release within the CNS. The company's lead program, NicaPlant®, targets severe neurological conditions with high unmet need, leveraging a management team with deep industry experience in drug development and neurosurgery. BIT Pharma is currently pre-revenue, having been initially funded by Austrian government seed financing.
View full company profile